Ca2+ stores and capacitative Ca2+ entry in human neuroblastoma (SH-SY5Y) cells expressing a familial Alzheimer's disease presenilin-1 mutation

Brain Research

Volumn 949, Issue 1-2, 2002, Pages 105-111

  Smith, I F ^a   Boyle, J P ^a   Vaughan, P F T ^a   Pearson, H A ^a   Cowburn, R F ^b   Peers, C S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Calcium store; Capacitative calcium entry; Human neuroblastoma; Presenilin

Indexed keywords

CALCIUM ION; FURA 2; MUSCARINE; MUSCARINIC RECEPTOR; PRESENILIN 1; THAPSIGARGIN;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROFLUOROMETRY; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ALZHEIMER DISEASE; BLOTTING, WESTERN; CALCIUM; CELL CULTURE TECHNIQUES; EXONS; HUMANS; MEMBRANE PROTEINS; MUSCARINE; MUSCARINIC AGONISTS; MUTATION; NEUROBLASTOMA; PRESENILIN-1; RECEPTORS, MUSCARINIC; TIME FACTORS;

EID: 0037072511     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02970-0     Document Type: Article

References (25)

1. Begley J.G., Duan W., Chan S., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72:1999;1030-1039.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Chan S.L., Mayne M., Holden C.P., Geiger J.D., Mattson M.P. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons. J. Biol. Chem. 275:2000;18195-18200.
4. De Strooper B., Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113:2000;1857-1870.
5. Duchen M.R. Fluorescence - monitoring cell chemistry in vivo. Stamford J.A., Monitoring Neuronal Activity; A Practical Approach. 1992;231-260 Oxford University Press, Oxford.
6. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
7. Leissring M.A., Akbari Y., Fanger C., Cahalan M.D., Mattson M.P., LaFerla F.M. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149:2000;793-797.
8. Leissring M.A., Parker I., LaFerla F.M. Presenilin-2 mutations modulate amplitude and kinetics of inositol 1,4,5-trisphosphate-mediated calcium signals. J. Biol. Chem. 274:1999;32535-32538.
9. Levitan D., Lee J., Song L., Manning R., Wong G., Parker E., Zhang L. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signalling. Proc. Natl. Acad. Sci. USA. 98:2001;12186-12190.
10. Mattson M.P. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1997;1081-1132.
11. Mattson M.P., Guo Q., Pedersen W.A. Presenilins, the endoplasmic reticulum and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70:1998;1-14.
12. Mattson M.P., Zhu H., Yu J., Kindy M.S. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of peterbed calcium homeostasis. J. Neurosci. 20:2000;1358-1364.
13. A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium. Neurosci. Lett. 199:1995;115-118.
14. i in human neuroblastoma (SH-SY5Y) cells expressing recombinant rat angiotensin 1A receptors by angiotensin and carbachol. J. Pharmacol. Exp. Ther. 281:1997;1257-1263.
15. Murphy N.P., Vaughan P.F.T., Ball S.G., McCormack J.G. The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. J. Neurochem. 57:1991;2116-2123.
16. 3H]noradrenaline from SH-SY5Y cells. J. Neurochem. 64:1995;1175-1182.
17. i.. Mol. Brain Res. 87:2001;81-91.
18. Selkoe D.J. Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81:2001;741-766.
19. Tanii H., Ankarcrona M., Flood F., Nilsberth C., Mehta N.D., Perez-Tur J., Winblad B., Benedikz E., Cowburn R.F. Alzheimer's disease presenilin-1 exon 9 deletion and L250S mutations sensitize SH-SY5Y neuroblastoma cells to hyperosmotic stress-induced apoptosis. Neuroscience. 95:2000;593-601.
20. Thinakaran G., Borchelt D.R., Lee M.K., Slunt H.H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A.I., Gandy S.E., Jenkins N.A., Copeland N.G., Price D.L., Sisodia S.S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
21. Vaughan P.F.T., Peers C., Walker J.H. The regulation of noradrenaline release by receptors and second messengers in the human neuroblastoma clone SH-SY5Y. Curr. Top. Neurochem. 1:1997;195-209.
22. Vaughan P.F.T., Walker J.H., Peers C. The regulation of neurotransmitter secretion by protein kinase C. Mol. Neurobiol. 18:1998;125-155.
23. Wolfe M.S., Haass C. The role of presenilins in γ-secretase activity. J. Biol. Chem. 276:2001;5413-5416.
24. Yoo A.S., Cheng I., Chung S., Grenfell T.Z., Lee H., Pack-Chung E., Handler M., Shen J., Xia W., Tesco G., Saunders A.J., Ding K., Frosch M.P., Tanzi R.E., Kim T.W. Presenilin-mediated modulation of capacitative calcium entry. Neuron. 27:2000;561-572.
25. Yu G., Nishimura M., Arawaka S., Levitan D., Zhang L., Tandon A., Song Y.Q., Rogaeva E., Chen F., Kawarai T., Supala A., Levesque L., Yu H., Yang D.S., Holmes E., Milman P., Liang Y., Zhang D.M., Xu D.H., Sato C., Rogaev E., Smith M., Janus C., Zhang Y., Aebersold R., Farrer L.S., Sorbi S., Bruni A., Fraser P., St George-Hyslop P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 407:2000;48-54.